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As scientists, communication—not only with those outside our area
of expertise but also with those within our scientific sphere—is an
important responsibility, though often an ongoing challenge. As
NIEHS director, I increasingly realize that, as the writer André Gide
said, “The most important things to say are those which often I did
not think necessary for me to say—because they were too obvious.”
In this case, the thing that I thought was obvious, but now believe
needs to be clearly
reiterated and more
fully described, is the
focus of my vision and
the work of this insti-
tute on the prevention
of human disease. 
In retrospect, I can
see how discussions of
my role as a physician
and my strong empha-
sis on the value of
clinical and transla-
tional research to the
environmental health
sciences may have cre-
ated a misperception
that my sole interest is
clinical disease. People
tend to talk most often
and loudly about those
things which they are
passionate about. In reality, it is my role as a physician that has
enabled me to recognize that clinical research and fundamental
research in disease prevention are not separate paths, but rather intri-
cately and necessarily connected approaches to achieving health.
Though I have witnessed the enormous value of clinical and transla-
tional research to  alleviate suffering from disease, I deeply believe
that a far greater impact on human health can be attained by har-
nessing the power of this research toward understanding the etiology
of disease and focusing this knowledge on preventing illness and
death. It is this concept that is embodied in the NIEHS vision,
which, as stated in our Strategic Plan, is “to prevent disease and
improve human health by using environmental sciences to under-
stand human biology and human disease.” 
A changing concept of disease prevention may also contribute to
confusion on this issue. There are different approaches to preventing
environmentally mediated disease. The first is to prevent all exposure
to harmful environmental agents. The historical work of this insti-
tute has had a profound effect in this area by identifying agents such
as metals, chemicals, and pollutants, and informing public policies to
protect against them. But technology, time, money, and behavioral
and societal factors are all real and constant hindrances to these
efforts. A second approach is to identify those populations who may
be most susceptible to environmental insults due to factors such as
age, genetics, and health status, and then prevent exposures to these
populations discretely. Ongoing studies funded by the NIEHS are
focused on examining just such populations, but many of the same
limitations of the first approach also apply here. A third approach,
intervention between exposure and disease, is the most ambitious
scientifically and a natural progression of the field of environmental
health. Ambitious because we are pushing the bounds of knowledge
and technology in our quest for understanding the biological effects of
environmental exposures on mechanisms of human disease, and a nat-
ural progression because
of the enormous poten-
tial of this approach to
change the way we view
disease and our ability to
prevent it.
In reality, all three
approaches complement
each other and will con-
tinue to be part of our
arsenal of disease pre-
vention tools. Examples
from the NIEHS research
portfolio illustrate vari-
ous ways in which we
are exploring disease pre-
vention strategies. A pro-
ject in a low-income
community in Washing-
ton State is implement-
ing multilevel strategies
including innovative
housing for people with asthma, clinical asthma care, in-home
education, and resident empowerment, along with scientific assess-
ment and analysis, to decrease asthma morbidity and improve the
built environment of public housing. Another project is developing
bioinformatics tools to identify polymorphic promoter response ele-
ments in candidate environmental response genes such as p53 to
help determine the limits of human variability in risk assessment and
thereby aid in disease prevention. The newly instituted Exposure
Biology Program will move the science toward intervention between
exposure and disease by providing sensitive biomarkers of exposure,
susceptibility, and early biological response. 
It is my belief that in the near future, the greatest impacts on
global environmental health in terms of reduced morbidity and mor-
tality will be made through breakthroughs in our basic understand-
ing of the causes and mechanisms of disease. As we continue to
develop new directions and priorities for the NIEHS, I hope that it
will become ever more clear that in no way are we abandoning our
long-held goal of disease prevention, but rather we are expanding
our sights and exploring new pathways for understanding human
biology and disease, always with this critical goal in mind. 
David A. Schwartz, MD
Director, NIEHS and NTP
E-mail: david.schwartz@niehs.nih.gov
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New Pathways to 
Disease Prevention
T he greatest impacts 
on global environmental
health will be made through
breakthroughs in our basic 
understanding of the causes
and mechanisms of disease.